Most of our understanding of the mechanisms that underly AD pathology are limited to rodent models of familial AD based on misexpression of different APP or Tau transgenes that do not recapitulate progressive neurodegeneration and all of the behavioral hall marks of the disease. The gene discussed is MAPT; the disease is Alzheimer disease.